Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tempus AI Cl A (TEM)

Tempus AI Cl A (TEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Cathie Wood Just Bet $26 Million on Broadcom Stock. Should You Buy AVGO Too?

Broadcom (AVGO) powers the digital world with cutting-edge semiconductors and software. The company produces chips for data centers, networking, broadband, wireless devices, and infrastructural solutions connecting everything from your smartphone to massive cloud systems. Key products include Wi-Fi chips, Ethernet switches, optical transceivers, and custom controllers, fueling AI growth and high-speed connectivity.

Founded in 1991, Broadcom is headquartered in Palo Alto, California, with operations spanning across 25 countries.

Fundamentals

See More
  • Market Capitalization, $K 11,298,872
  • Shares Outstanding, K 177,907
  • Annual Sales, $ 693,400 K
  • Annual Income, $ -705,810 K
  • EBIT $ -242 M
  • EBITDA $ -198 M
  • 60-Month Beta 5.22
  • Price/Sales 10.21
  • Price/Cash Flow N/A
  • Price/Book 22.62

Options Overview Details

View History
  • Implied Volatility 66.96% (+1.31%)
  • Historical Volatility 55.20%
  • IV Percentile 13%
  • IV Rank 8.60%
  • IV High 133.93% on 04/08/25
  • IV Low 60.65% on 12/10/25
  • Expected Move (DTE 7) 3.82 (6.27%)
  • Put/Call Vol Ratio 0.62
  • Today's Volume 21,349
  • Volume Avg (30-Day) 23,971
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 252,183
  • Open Int (30-Day) 306,948
  • Expected Range 57.05 to 64.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.28
  • Number of Estimates 5
  • High Estimate -0.25
  • Low Estimate -0.33
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +15.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.80 +1.96%
on 12/31/25
76.33 -21.46%
on 01/12/26
-0.44 (-0.73%)
since 12/30/25
3-Month
58.80 +1.96%
on 12/31/25
90.53 -33.78%
on 11/03/25
-26.32 (-30.51%)
since 10/30/25
52-Week
36.22 +65.52%
on 04/09/25
104.32 -42.53%
on 10/09/25
+2.76 (+4.83%)
since 01/30/25

Most Recent Stories

More News
Cathie Wood Just Bet $26 Million on Broadcom Stock. Should You Buy AVGO Too?

Cathie Wood bets on Broadcom while shorting major market names in a week of activity.

BLSH : 30.15 (-7.69%)
ARKX : 32.04 (-3.38%)
NFLX : 83.56 (+0.48%)
META : 717.83 (-2.77%)
ROKU : 95.42 (-5.02%)
TXG : 20.14 (-3.17%)
GTLB : 34.87 (-1.77%)
AVGO : 331.31 (+0.18%)
TWST : 40.99 (-1.42%)
ILMN : 144.43 (-3.51%)
CRCL : 63.73 (-5.66%)
WRD : 8.00 (-3.15%)
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune...

TEM : 59.75 (-5.92%)
Pelosi’s Bullish 2026 Buy List: AI, Power & Dividends

The famous congressional portfolio is rotating capital into dividend-paying financial stocks while doubling down on artificial intelligence and energy.

AB : 42.38 (+2.64%)
NVDA : 191.04 (-0.76%)
GOOGL : 339.08 (+0.25%)
AAPL : 261.78 (+1.36%)
VST : 158.84 (-2.30%)
TEM : 59.75 (-5.92%)
AMZN : 239.86 (-0.77%)
Tempus Announces the Launch of Paige Predict

Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital pathology

TEM : 59.75 (-5.92%)
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation’s premier academic medical centers, today announced a multi-year strategic collaboration...

TEM : 59.75 (-5.92%)
Northwestern Medicine Selects Tempus to Expand Genomic Testing

Collaboration will focus on the oncology patient population

TEM : 59.75 (-5.92%)
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion

Reported preliminary, unaudited Data and application revenue of ~$316 million for the full year 2025, representing ~31% year-over-year growth, with Insights (data licensing) growing 38% ...

TEM : 59.75 (-5.92%)
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced select, preliminary, unaudited results for the fourth quarter and full year...

TEM : 59.75 (-5.92%)
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO ...

TEM : 59.75 (-5.92%)
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place January...

TEM : 59.75 (-5.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery,...

See More

Key Turning Points

3rd Resistance Point 65.84
2nd Resistance Point 65.03
1st Resistance Point 64.27
Last Price 59.75
1st Support Level 62.70
2nd Support Level 61.89
3rd Support Level 61.13

See More

52-Week High 104.32
Fibonacci 61.8% 78.31
Fibonacci 50% 70.27
Fibonacci 38.2% 62.23
Last Price 59.75
52-Week Low 36.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar